Initiating a conversation on patient cases, Divya Gupta, MD, presents the profile of a 76-year-old woman with ROS1+ metastatic non–small cell lung cancer.
HER3-DXd Significantly Improves PFS Vs Chemo in Advanced EGFR+ NSCLC
HERTHENA-Lung02 investigators will present further data from the trial at a future medical meeting.
Optimizing NSCLC Outcomes Via Technological Advances in Radiation Oncology
Terence T. Sio, MD, MS, highlights advances such as proton beam radiotherapy that may improve outcomes for those with non–small cell lung cancer.
Superiority Noted in Adagrasib Vs Docetaxel in Patients With KRAS G12C-Mutated NSCLC
Superior efficacy outcomes were noted when adagrasib was used to treat patients with KRAS G12C NSCLC and among those with brain metastases.
Moving The Needle in Lung Cancer Management With Robotic-Assisted Surgery
Richard Lazzaro, MD, discusses how a robot-assisted platform has impacted his thoracic surgery and highlights other potential advancements in the field.
Amivantamab/Chemo Shows Sustained OS in Advanced EGFR+ NSCLC
Amivantamab plus chemotherapy also improved time to symptomatic progression among patients enrolled on the MARIPOSA-2 trial.
Belrestotug/Dostarlimab Improves ORR in PD-L1–High NSCLC
Data from the GALAXIES-Lung 201 trial found efficacy improvement in patients with advanced NSCLC.